Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience

Abstract

Although several facets of this manufacturing process still need to be improved, these data may yet provide a useful platform for the production of hESC-derived cardiac progenitor cells under safe and cost-effective GMP conditions.